El Hospital Universitario Virgen de Valme es un complejo hospitalario público gestionado por el Servicio Andaluz de Salud, ubicado en la ciudad española de Sevilla. Tiene función asistencial y docente, estando afiliada al mismo la Facultad de Medicina de la Universidad de Sevilla.​

During the past decade, Hospital Universitario Virgen de Valme conducted 110 clinical trials. In the 10-year time frame, 110 clinical trials started and 48 clinical trials were completed, i.e. on average, 43.6% percent of trials that started reached the finish line to date. In the past 5 years, 58 clinical trials started and 28 clinical trials were completed. i.e. 48.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Universitario Virgen de Valme" #1 sponsor was "Pfizer" with 12 trials, followed by "Gilead Sciences" with 9 trials sponsored, "PETHEMA Foundation" with 8 trials sponsored, "Boehringer Ingelheim" with 7 trials sponsored and "Fundación Pública Andaluza Progreso y Salud" with 7 trials sponsored. Other sponsors include 136 different institutions and companies that sponsored additional 93 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitario Virgen de Valme" #1 collaborator was "Eli Lilly and Company" with 6 trials as a collaborator, "Bristol-Myers Squibb" with 4 trials as a collaborator, "Hospital Universitario Virgen Macarena" with 4 trials as a collaborator, "Hospital Universitario Virgen de la Victoria" with 4 trials as a collaborator and "Hospital Universitario Reina Sofia de Cordoba" with 3 trials as a collaborator. Other collaborators include 110 different institutions and companies that were collaborators in the rest 99 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Universitario Virgen de Valme" are "Chronic Hepatitis C" (6 trials), "Breast Cancer" (5 trials), "Diabetes Mellitus, Type 2" (5 trials), "HIV Infection" (5 trials) and "Hepatitis C, Chronic" (5 trials). Many other conditions were trialed in "Hospital Universitario Virgen de Valme" in a lesser frequency.

Most popular intervention types in "Hospital Universitario Virgen de Valme" are "Drug" (134 trials), "Other" (14 trials), "Biological" (12 trials), "Device" (5 trials) and "Procedure" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (37 trials), "Guselkumab" (5 trials), "Dexamethasone" (4 trials), "Docetaxel" (4 trials) and "Lenalidomide" (4 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitario Virgen de Valme" are 163 trials for "All" genders, 19 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Universitario Virgen de Valme". 2 are not yet recruiting, 32 are recruiting, 18 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 95 completed trials in Hospital Universitario Virgen de Valme, undefined suspended trials, and 19 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitario Virgen de Valme, 4 "Phase 1" clinical trials were conducted, 40 "Phase 2" clinical trials and 75 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 18 trials, and there were also 14 trials that are defined as “Not Applicable".